1-[(5-Ethylthiophen-2-yl)methyl]-1h-imidazol-2-amine

Catalog No.: 
ACVOLD746
CAS No.: 
1250931-89-5
Molecular Formula: 
C10H13N3S
Molecular Weight: 
207.30
1-[(5-Ethylthiophen-2-yl)methyl]-1h-imidazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$202.00InquiryInquiry
1g95%$635.00InquiryInquiry
5g95%$3112.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(5-Ethylthiophen-2-yl)methyl]-1h-imidazol-2-amine
IUPAC Name1-((5-ethylthiophen-2-yl)methyl)-1H-imidazol-2-amine
MDL No.MFCD16707865
Molecular FormulaC10H13N3S
Molecular Weight207.30
SMILESNC1=NC=CN1CC2=CC=C(CC)S2
InChI KeyGTCONONFOUQHNI-UHFFFAOYSA-N
Synonym1H-Imidazol-2-amine, 1-[(5-ethyl-2-thienyl)methyl]-;1-((5-Ethylthiophen-2-yl)methyl)-1h-imidazol-2-amine
CAS No.1250931-89-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACVOLD746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYJZ217 route compound structure diagram
    ACAYJZ2177720-39-0In Stock
  4. Then
  5. ACVOLD746 route product structure diagram
    ACVOLD7461250931-89-5
Inquiry

2. ACVOLD746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYJZ217 route compound structure diagram
    ACAYJZ2177720-39-0In Stock
  4. Then
  5. ACVOLD746 route product structure diagram
    ACVOLD7461250931-89-5
Inquiry

3. ACVOLD746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVOLD746 route product structure diagram
    ACVOLD7461250931-89-5
Inquiry

Comments (0)